TY - JOUR
T1 - Reactive oxygen species-dependent HSP90 protein cleavage participates in arsenical As+ 3- and MMA+ 3-induced apoptosis through inhibition of telomerase activity via JNK activation
AU - Shen, Shing Chuan
AU - Yang, Liang Yo
AU - Lin, Hui Yi
AU - Wu, Chin Yen
AU - Su, Tsung Hsien
AU - Chen, Yen Chou
N1 - Funding Information:
This study was supported by the National Science Council of Taiwan (NSC95-2320-B-038-029-MY2, NSC96-2320-B-038-031-MY3, NSC96-2320-B-038-022), 96TMU-WFH-04, and 93MMH-TMU-05.
PY - 2008/6/1
Y1 - 2008/6/1
N2 - The effects of six arsenic compounds including As+ 3, MMA+ 3, DMA+ 3, As+ 5, MMA+ 5, and DMA+ 5 on the viability of NIH3T3 cells were examined. As+ 3 and MMA+ 3, but not the others, exhibited significant cytotoxic effects in NIH3T3 cells through apoptosis induction. The apoptotic events such as DNA fragmentation and chromosome condensation induced by As+ 3 and MMA+ 3 were prevented by the addition of NAC and CAT, and induction of HO-1 gene expression in accordance with cleavage of the HSP90 protein, and suppression of telomerase activity were observed in NIH3T3 cells under As+ 3 and MMA+ 3 treatments. An increase in the intracellular peroxide level was examined in As+ 3- and MMA+ 3-treated NIH3T3 cells, and As+ 3- and MMA+ 3-induced apoptotic events were blocked by NAC, CAT, and DPI addition. HSP90 inhibitors, GA and RD, significantly attenuated the telomerase activity in NIH3T3 cells with an enhancement of As+ 3- and MMA+ 3-induced cytotoxicity. Suppression of JNKs significantly inhibited As+ 3- and MMA+ 3-induced apoptosis by blocking HSP90 protein cleavage and telomerase reduction in NIH3T3 cells. Furthermore, Hb, SnPP, and dexferosamine showed no effect against As+ 3- and MMA+ 3-induced apoptosis, and overexpression of HO-1 protein or inhibition of HO-1 protein expression did not affect the apoptosis induced by As+ 3 or MMA+ 3. These data provide the first evidence to indicate that apoptosis induced by As+ 3 and MMA+ 3 is mediated by an ROS-dependent degradation of HSP90 protein and reduction of telomerase via JNK activation, and HO-1 induction might not be involved.
AB - The effects of six arsenic compounds including As+ 3, MMA+ 3, DMA+ 3, As+ 5, MMA+ 5, and DMA+ 5 on the viability of NIH3T3 cells were examined. As+ 3 and MMA+ 3, but not the others, exhibited significant cytotoxic effects in NIH3T3 cells through apoptosis induction. The apoptotic events such as DNA fragmentation and chromosome condensation induced by As+ 3 and MMA+ 3 were prevented by the addition of NAC and CAT, and induction of HO-1 gene expression in accordance with cleavage of the HSP90 protein, and suppression of telomerase activity were observed in NIH3T3 cells under As+ 3 and MMA+ 3 treatments. An increase in the intracellular peroxide level was examined in As+ 3- and MMA+ 3-treated NIH3T3 cells, and As+ 3- and MMA+ 3-induced apoptotic events were blocked by NAC, CAT, and DPI addition. HSP90 inhibitors, GA and RD, significantly attenuated the telomerase activity in NIH3T3 cells with an enhancement of As+ 3- and MMA+ 3-induced cytotoxicity. Suppression of JNKs significantly inhibited As+ 3- and MMA+ 3-induced apoptosis by blocking HSP90 protein cleavage and telomerase reduction in NIH3T3 cells. Furthermore, Hb, SnPP, and dexferosamine showed no effect against As+ 3- and MMA+ 3-induced apoptosis, and overexpression of HO-1 protein or inhibition of HO-1 protein expression did not affect the apoptosis induced by As+ 3 or MMA+ 3. These data provide the first evidence to indicate that apoptosis induced by As+ 3 and MMA+ 3 is mediated by an ROS-dependent degradation of HSP90 protein and reduction of telomerase via JNK activation, and HO-1 induction might not be involved.
KW - Apoptosis
KW - Arsenics
KW - Heat shock protein 90
KW - Heme oxygenase 1
KW - ROS
KW - Telomerase
UR - http://www.scopus.com/inward/record.url?scp=43449105876&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43449105876&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2008.01.018
DO - 10.1016/j.taap.2008.01.018
M3 - Article
C2 - 18336854
AN - SCOPUS:43449105876
SN - 0041-008X
VL - 229
SP - 239
EP - 251
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 2
ER -